Achillion Names Dr. Joel Barrish as Chief Scientific Officer By: Benzinga via Benzinga January 04, 2016 at 06:21 AM EST Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN) today announced that Joel Barrish, Ph.D., has been named the Company's Chief Scientific ... Read More >> Related Stocks: Achison Inc